$ Value
$8K
Shares
1,137
Price
$7
Filed
Nov 19
Insider
Name
Medlin Derek
Title
Chief Operating Officer
CIK
0001866031
Roles
Transaction Details
Transaction Date
2024-11-15
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
65,006
Footnotes
On September 9, 2021, the reporting person was granted 110,213 restricted stock units ("RSUs") (which, following the Issuer's July 27, 2023 1-for-25 reverse stock split, resulted in 4,409 RSUs), 25% of which vested on March 15, 2022, with the remainder scheduled to vest thereafter in 12 quarterly installments on each of May 15, August 15, November 15 and February 15 subject to the reporting person's continued employment with the Issuer on each applicable vesting date (the "2021 Award"). The reporting person has reported prior grants of RSUs under the 2021 Award in Table II of Form 4. | On March 15, 2022, the reporting person was granted 592,946 RSUs (which, following the Issuer's July 27, 2023 1-for-25 reverse stock split, resulted in 23,718 RSUs), 25% of which vested on March 15, 2023, with the remainder scheduled to vest thereafter in 12 quarterly installments on each of May 15, August 15, November 15 and February 15 subject to the reporting person's continued employment with the Issuer on each applicable vesting date (the "2022 Award"). | The shares reported in Column 4 are shares withheld for the payment of taxes associated with the 2021 Award and 2022 Award and were previously included in the shares reported under Transaction Code F in Table I of the Form 4 filed on November 17, 2023. | On June 16, 2023, the reporting person was granted 385,000 RSUs (which, following the Issuer's July 27, 2023 1-for-25 reverse stock split, resulted in 15,400 RSUs), one-third of which vested on March 15, 2024, and the remainder scheduled to vest thereafter in eight quarterly installments on each of May 15, August 15, November 15 and February 15 subject to the reporting person's continued employment with the Issuer on each applicable vesting date (the "2023 Award"). | The shares reported in Column 4 are shares withheld for the payment of taxes associated with the 2021 Award, 2022 Award and 2023 Award. | On May 6, 2024, the reporting person was granted 20,000 RSUs, one-third of which vested on March 15, 2025, and the remainder scheduled to vest thereafter in eight quarterly installments on each of May 15, August 15, November 15 and February 15 subject to the reporting person's continued employment with the Issuer on each applicable vesting date (the "2024 Award"). | The shares reported in Column 4 are shares withheld for the payment of taxes associated with the 2021 Award, 2022 Award and 2024 Award. | The shares reported in Column 4 are shares withheld for the payment of taxes associated with the 2022 Award, 2023 Award and 2024 Award.
Filing Info
Medlin Derek's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-15 | KPLT | F | $12K |
| 2025-11-17 | KPLT | F | $10K |
| 2025-08-15 | KPLT | F | $23K |
| 2025-05-15 | KPLT | F | $13K |
| 2025-03-15 | KPLT | F | $30K |
| 2025-02-15 | KPLT | F | $13K |
| 2024-11-15 | KPLT | F | $8K |
| 2024-08-15 | KPLT | F | $15K |
| 2024-05-15 | KPLT | F | $21K |
| 2023-08-15 | KPLT | F | $304K |
Other Insiders at KPLT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Walsh Nancy A
Chief Financial Officer
|
— | — | 2026-02-15 |
|
Zayas Orlando
Chief Executive Officer
|
— | — | 2026-02-15 |
|
Medlin Derek
Chief Operating Officer
|
— | — | 2026-02-15 |